1. The above results were reviewed by the audit committee and taken on record by the Board of Directors at its meeting held on 28.04.2006
2. The Company is exclusively in the Pharmaceutical business segment.
3. Company’s two new facilities one 100% EOU located at Jawaharpur, Punjab to focus on exports to soft regulated and non regulated markets and a new formulations unit at Baddi, to cater to the domestic market were completed during the quarter. The company now has six manufacturing facilities located in four different states. The Company expects additional revenue generation of Rs. 160 Crores and a net profit of Rs. 12.5 Crores from the three new facilities completed in FY 2005-06
4. The figures of the Net Profit of the quarter and the financial year ended 3103.2006 and 31.03.2005 are not comparable as the profit for the period ended 31.03.2005 included the other income of Rs. 240.88 & Rs. 1304.56 Lacs respectively form the sale of shares.
5. For the financial year 2005-06, excluding the extra ordinary income of Rs. 1304 Lacs form sale of shares, the company’s income from operation grew by 14.19% and Net Profit after tax grew by 36.22%.
6. Implementation of VAT on the four major states during the last quarter of the FY 2005-06 has impacted the turnover and the net profit of the company for the quarter, which the company expects to be for short term.
7. Investor Complaints for the Quarter: Opening – Nil, Received – 17, Redressed – 17, Closing balance -Nil.